Physician profile
Meredith White
NPI 1649716796
$5,162.87
in general payments reported to CMS, 2019-2025
12 companies · $2,155 in 2025
The $2,155 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $48.76 · 2023: $1,164 · 2024: $1,796 · 2025: $2,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,974 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,974.13 |
| Education | $139.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,189.18 | 2023-2025 | |
| Amgen INC. | $1,265.21 | 2023-2025 | Enbrel, Otezla, Tavneos |
| Janssen Biotech, INC. | $462.24 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $386.00 | 2023-2025 | |
| Ucb, INC. | $348.11 | 2023-2025 | Bimzelx, Cimzia |
| Glaxosmithkline, LLC. | $197.53 | 2022-2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $193.08 | 2022-2025 | Saphnelo |
| Genzyme Corporation | $43.11 | 2023-2025 | |
| Invivyd INC | $30.54 | 2025 | Pemgarda |
| Lilly USA, LLC | $19.59 | 2025 | Taltz |
| Sandoz INC. | $15.80 | 2023 | Hyrimoz |
| Mallinckrodt Hospital Products INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.